As a result, we encourage other nonprofit newsrooms, mission-aligned outlets, and advocacy organizations to republish our original content under the following conditions: 1
Comparing Clinical Evidence: GLP-1 Receptor Agonists vs Antioxidant Therapy Randomized controlled trials of semaglutide, including SUSTAIN and STEP studies, consistently show significant weight loss, improved blood sugar control, and reduced cardiovascular risk markers
The dosages seem to be more along the lines of 150mcg-300mcg whereas many of the pill forms are 25mg-50mg
Some researchers administer the blend locally for tendon or joint-specific applications, while others use systemic administration for multi-site or whole-body recovery protocols
References Hanif M, Nagarajan JS, Murphy R, et al
Ozempic and Mounjaro are FDA-approved for type 2 diabetes treatment, but may be prescribed off-label for weight loss at a healthcare providers discretion